Cancer Medicine

Dr Wei is a highly published and cited author who is based at the world’s leading cancer research centre. His previous editorial work includes a role as a Senior Editor on the AACR journal Cancer Epidemiology, Biomarkers & Prevention.

His primary research interest is to explore and develop biomarkers for molecular epidemiologic study for assessing cancer susceptibility with an emphasis on DNA repair and apoptosis. His research is aimed at identifying individuals at high risk of developing cancer. This allows for personalisation in cancer research, with an aim to achieve primary prevention, early diagnosis and targeted therapies. The biomarker assays used in his lab are used in studies of cancers of the lung, head and neck cancer, skin, and breast.

Dr Wei’s recent works include genome-wide association study of melanoma, miRNA variants in an apoptosis gene and risk of head and neck cancer, DNA repair capacity phenotype and survival of lung cancer patients with chemotherapy,TGFβ1 gene variants and risk of radiation pneumonitis in lung cancer patients with definitive radiotherapy, and functional single nucleotide polymorphism in the MIIP gene and risk of breast cancer.

Read Dr Wei's editorial: ‘Personalized medicine at a prime time for cancer medicine – Introducing Cancer Medicine’.

Wiley Open Access has a number of social media outlets where you can get updates about Cancer Medicine.

Cancer Medicine's fifth issue brings together articles on a range of oncology specialties, such as cancer biology, clinical cancer research, and cancer prevention, with authors from across the globe. Below are some top articles to highlight from the most recent issue, selected by Editor-in-Chief Prof. Qingyi Wei:

GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression
by Claudia M. Gutschalk, Archana K. Yanamandra, Nina Linde, Alice Meides, Sofia Depner, and Margareta M. Mueller

Characterization of the melanoma brain metastatic niche in mice and humans
by Moran Amit, Leonor Laider-Trejo, Vardit Shalom, Ayelet Shabtay-Orbach, Yakov Krelin, and Ziv Gil

Complexity in cancer biology: is systems biology the answer?
by Evangelia Koutsogiannouli, Athanasios G. Papavassiliou, and Nikolaos A. Papanikolaou

Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo
by Emilie Nouguerede, Caroline Berenguer, Stephane Garcia, Bahia Bennani, Christine Delfino, Isabelle Nani, Laetitia Dahan, Mohamed Gasmi, Jean-Francois Seitz, Pierre-Marie Martin, and L'Houcine Ouafik

Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?
by Edward Cha and Eric J. Small

Submit an Article

We would like to invite you to submit your paper to Cancer Medicine. Reasons to submit:

• High standard, rigorous peer review  
• International Editorial Board
• Rapid publication
• Open access and fully compliant with open access mandates
• Authors retain copyright
• Wiley's tradition in publishing excellence

Submit a manuscript >

Cancer Medicine is supported by other journals published by Wiley on behalf of the world's most prestigious cancer societies. The journals listed below support Cancer Medicine and participate in the Manuscript Transfer Program by referring articles of suitable quality and offering authors the option to have their paper, with any peer review reports, automatically transferred to Cancer Medicine.